Mark A. Velleca - Director at G1 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GTHX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark A. Velleca - trading volume in the past year for G1 Therapeutics, Inc.

Holdings reported by Mark A. Velleca for G1 Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 116,000 $341 K $2.94 Aug 8, 2023 Direct
Stock Option (Right to Buy) 242,286 Aug 8, 2023 Direct Common Stock

Transactions reported by Mark A. Velleca for G1 Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership